title: Is systemic autoimmune disease a risk factor for terbinafine-induced erythema multiforme?
authors.forename: V
authors.initials: V
authors.lastname: Goeteyn
authors.forename: J M
authors.initials: JM
authors.lastname: Naeyaert
authors.forename: J
authors.initials: J
authors.lastname: Lambert
authors.forename: L
authors.initials: L
authors.lastname: Monbaliu
authors.forename: F
authors.initials: F
authors.lastname: Vermander
mesh_terms: D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000150:complications*; D004892:Erythema Multiforme / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014009:Onychomycosis / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000935:Antifungal Agents